Picture of DURECT logo

DRRX — DURECT News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Durect Corp Expected To Post A Loss Of 4 Cents A Share: Earnings Preview

* DURECT Corp  DRRX.OQ   DRRX.O  is expected to show a rise in
quarterly revenue when it reports results on May 4.
* The Cupertino, California-based company is expected to report
 a 8.2% increase in revenue to $3.003 million from $2.78 million
a year ago, according to the mean estimate from 6 analysts,
based on Refinitiv data.​​
​* Refinitiv's mean analyst estimate for DURECT Corp is for a
loss of 4 cents per share. For the same quarter last year, the
company reported a loss of 5 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts had risen by
about 24.0% in the last three months.​
* Wall Street's median 12-month price target for DURECT Corp is
$6.5​, about 70.8% above​ its last closing price of $1.90. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  0.02        -0.03      -0.04     Missed  -26.3
 Sep. 30 2020  -0.04       -0.04      -0.05     Missed  -15.4
 Jun. 30 2020  0.02        0.02       0.07      Beat    366.7​
 Mar. 31 2020  -0.03       -0.04      -0.05     Missed  -38.9
 Dec.          0.00​       -0.02      -0.02     Met     -25​
 31​ 2019​                                              
 Sep. 30 2019  0.03        0.02       -0.01     Missed  -150​
 Jun. 30 2019  -0.04       -0.04      -0.04     Met     11.1
 Mar. 31 2019  -0.05       -0.05      -0.04     Beat    14.3
 This summary was machine generated May 1 at 02:01 GMT.  All
figures in US dollars unless otherwise stated

Recent news on DURECT

See all news